Dabur Smritisagar Ras Tablet is an amalgamation of ingredients that work together to help treat epilepsy and symptoms like fainting and temporary confusion. It is used in the treatment of memory loss and numbness in the hands and feet.
-10%
Dabur Sitopaladi Churna 60gm
Original price was: ₹130.00.₹117.00Current price is: ₹117.00.
Dabur Stresscom Ashwagandha Capsule
Original price was: ₹61.00.₹54.90Current price is: ₹54.90.
Dabur Smritisagar Ras Tablet
Original price was: ₹77.90.₹70.11Current price is: ₹70.11.
- It helps in treating or managing Epilepsy and the symptoms associated with it like fainting and temporary confusion
- It is used to treat memory loss
- It acts as a nervine tonic and helps treat numbness in the hands and feet
- It acts as a rejuvenator for the brain
Description
Reviews (0)
Related products
Baidyanath Swarna Maha Yograj Guggulu Tablet
Original price was: ₹238.00.₹215.00Current price is: ₹215.00.
Baidyanath Talisadi Churna
Original price was: ₹120.00.₹108.00Current price is: ₹108.00.
Baidyanath Tribhuwan Keerti Ras Tablet
Original price was: ₹123.00.₹110.00Current price is: ₹110.00.
Baidyanath Yogaraj Guggulu
Original price was: ₹150.00.₹135.00Current price is: ₹135.00.
Dabur Ablari
Original price was: ₹183.00.₹164.70Current price is: ₹164.70.
Dabur Amritarishta Syrup
Original price was: ₹120.00.₹108.00Current price is: ₹108.00.
The key ingredient Amrutha is known for its dosha-balancing properties and may help nourish the body tissues particularly (rasa and rakta dhatus)
The presence of Dashamoola (group of 10 roots) and Trikatu (dry ginger – pepper – long pepper) in this formulation may act on inflammatory conditions and the digestive system respectively
The formulation may also help to provide comfort in case of associated body aches and swollen joints
Ingredients like Trikatu and Musta improve digestion while Indrayava, Parpataka etc. help ama dosha (accumulated toxins) from the body
Dabur Lipistat Capsule
Original price was: ₹100.00.₹75.00Current price is: ₹75.00.
Reviews
There are no reviews yet.